GVOKE HYPOPEN
Xeris Pharmaceuticals, Inc.
Mark For: GVOKE HYPOPEN® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88011932 |
| Registration Number | 6136874 |
| Mark Literal Elements | GVOKE HYPOPEN |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | PUBLICATION AND ISSUE SECTION 2020-07-23 |
| Basis | 1(a) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | Yes |
| Intent To Use | No |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Alicia Morris Groos |
| Attorney Docket Number | 1001050873 |
| Law Office Assigned | L70 |
| Employee Name | KAPLAN, VALERIE ELIZAB |
Timeline
| 2018-06-22 | Application Filed |
| 2018-11-20 | Published |
| 2018-11-20 | Published for Opposition |
| 2019-01-15 | Location: INTENT TO USE SECTION |
| 2020-01-04 | Status: Live/Pending |
| 2020-01-07 | Transaction Date |
| 2020-06-29 | Date of First Use |
| 2020-06-29 | Date of Use In Commerce |
| 2020-07-23 | Location: PUBLICATION AND ISSUE SECTION |
| 2020-08-25 | Status: Registered. The registration date is used to determine when post-registration maintenance documents are due. |
| 2020-08-25 | Trademark Registered |
Trademark Parties (Applicants & Owners)
| Party: |  Xeris Pharmaceuticals, Inc. |
| Address | 180 N LaSalle Street, Suite 1810 Chicago, ILLINOIS UNITED STATES 60601 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
Documents
 Drawing | JPEG | 2018-06-22 |
 TEAS RF New Application | MULTI | 2018-06-22 |
| Notation to File | XML | 2018-10-11 |
| XSearch Search Summary | XML | 2018-10-11 |
| XSearch Search Summary | XML | 2018-10-11 |
| TRAM Snapshot of App at Pub for Oppostn | APPLICATION/XML,IMAGE/JPEG | 2018-10-12 |
| Notice of Publication | XML | 2018-10-31 |
| Notification Of Notice of Publication | XML | 2018-10-31 |
| OG Publication Confirmation | APPLICATION/XML | 2018-11-20 |
| Notice of Allowance | XML | 2019-01-15 |
| Extension of Time to File SOU | XML | 2019-06-21 |
| ITU Extension Approval | XML | 2019-06-25 |
| ITU Unit Action | MULTI | 2019-06-25 |
| Extension of Time to File SOU | XML | 2020-01-04 |
| ITU Extension Approval | XML | 2020-01-07 |
| ITU Unit Action | MULTI | 2020-01-07 |
| Change Address or Representation Form | XML | 2020-05-22 |
| Specimen | JPEG | 2020-07-02 |
| Statement of Use | MULTI | 2020-07-02 |
| ITU Unit Action | APPLICATION/XML,IMAGE/JPEG | 2020-07-24 |
| Notice of Acceptance of Statement of Use | XML | 2020-07-24 |
| TRAM Snapshot of App at Pub for Oppostn | MULTI | 2020-07-24 |
| Registration Certificate | 2020-08-25 |
Attorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical products for the treatment of diabetes and metabolic diseases; medical apparatus, namely, a drug delivery device prefilled with pharmaceutical products for the treatment of diabetes and metabolic diseases; pre-filled syringes and vials containing pharmaceutical preparations for the treatment of diabetes and metabolic diseases. FIRST USE: 20200629. FIRST USE IN COMMERCE: 20200629
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical products for the treatment of diabetes and metabolic diseases; medical apparatus, namely, a drug delivery device prefilled with pharmaceutical products for the treatment of diabetes and metabolic diseases; pre-filled syringes and vials containing pharmaceutical preparations for the treatment of diabetes and metabolic diseases |
| GS0051 | Pharmaceutical products for the treatment of diabetes and metabolic diseases; medical apparatus, namely, a drug delivery device prefilled with pharmaceutical products for the treatment of diabetes and metabolic diseases; pre-filled syringes and vials containing pharmaceutical preparations for the treatment of diabetes and metabolic diseases |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| REGISTERED-PRINCIPAL REGISTER | 2020-08-25 | |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2020-07-24 | |
| STATEMENT OF USE PROCESSING COMPLETE | 2020-07-23 | 66230 |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2020-07-23 | 66230 |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2020-07-23 | |
| USE AMENDMENT FILED | 2020-07-02 | 66230 |
| TEAS STATEMENT OF USE RECEIVED | 2020-07-02 | |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-05-22 | |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-05-22 | |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-05-22 | |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-05-22 | |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-05-22 | 88888 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-01-07 | |
| TEAS EXTENSION RECEIVED | 2020-01-04 | |
| EXTENSION 2 GRANTED | 2020-01-04 | 98765 |
| EXTENSION 2 FILED | 2020-01-04 | 98765 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-06-25 | |
| TEAS EXTENSION RECEIVED | 2019-06-21 | |
| EXTENSION 1 GRANTED | 2019-06-21 | 98765 |
| EXTENSION 1 FILED | 2019-06-21 | 98765 |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2019-01-15 | |
| PUBLISHED FOR OPPOSITION | 2018-11-20 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2018-11-20 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-10-31 | |
| ASSIGNED TO EXAMINER | 2018-10-11 | 92988 |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-10-11 | |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-06-29 | |
| NEW APPLICATION ENTERED IN TRAM | 2018-06-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 